Search - tctmd.com

Displaying 1 - 20 of 31

Sort: Relevancy | Date

News Conference News THT 2026

NT-proBNP Provides Info on Who Will Fare Well After Tricuspid TEER

Todd Neale

March 04, 2026

Presentation THT 2026

Preclinical Results of a Novel, Percutaneous Device to Reapproximate and Reshape the Right Ventricle in Functional Tricuspid Regurgitation with Right Ventricular Dysfunction

Presenter: Michael I. Brener

March 03, 2026

Presentation THT 2026

Impact of Baseline Tricuspid Regurgitation on Outcomes in Heart Failure Patients Undergoing Mitral TEER

Presenter: Thitiphan Srikulmontri

March 03, 2026

Presentation THT 2026

Central Venous Congestion in Transcatheter Tricuspid Repair: Lessons from the TRI.Fr Trial

Presenter: Karl-Philipp Rommel

March 03, 2026

Presentation THT 2026

Prognostic Value of NT-proBNP in Patients Undergoing Tricuspid Valve Transcatheter Edge-to-Edge Repair: The EuroTR Registry

Presenter: Jennifer von Stein

March 03, 2026

News Conference News THT 2025

Questioning the KCCQ: Experts Debate Its Validity as QoL Metric

Todd Neale

February 19, 2025

Presentation THT 2025

Navigating Conduction Abnormalities Following Transcatheter Tricuspid Valve Replacement (TTVR): A Single Center Experience

Presenter: Tooba Salar

February 12, 2025

Presentation THT 2025

Cardiomechanics in Patients Undergoing mTEER: Insights From PV Analysis

Presenter: Nicolas Van Mieghem

February 12, 2025

Presentation THT 2025

Strategies to Reduce the Burden of Residual MACE After mTEER in Patients With FMR

Presenter: Michael Brener

February 12, 2025

Presentation THT 2025

Pills, Drips and Pumps: Management of Volume Status and RV Dysfunction Before and After TTVI

Presenter: JoAnn Lindenfeld

February 12, 2025

Presentation THT 2025

Putting It All Together: A Case of TTVR

Presenter: Karl-Philipp Rommel

February 12, 2025

Presentation THT 2025

TTVI Trial Updates

Presenter: Rebecca Hahn

February 12, 2025

Presentation THT 2025

TRISCEND II Trial: Right Heart Failure Outcomes in Patients With Severe Tricuspid Regurgitation at One Year

Presenter: Aasim Afzal

February 11, 2025

Presentation THT 2024

Case 5: Tricuspid TEER for the Win

Presenter: Sameer Gafoor

March 05, 2024

News Conference News THT 2024

Debating the Role of T-TEER in the Sickest Patients

Michael O'Riordan

March 05, 2024

Presentation THT 2024

HF Specialist Perspectives and Role in TR Management

Presenter: Ulrich P. Jorde

March 04, 2024

Presentation THT 2024

Updates from Triluminate and TRISCEND II: Perspectives from the FDA Panel

Presenter: Susheel K. Kodali

March 04, 2024

Presentation THT 2023

Current Clinical Evidence Following TR Interventions

Presenter: Susheel Kodali

March 22, 2023

Presentation THT 2023

Treatment Algorithms: Matching Devices With Anatomy and Clinical Factors

Presenter: Azeem Latib

March 22, 2023

Presentation THT 2023

A Comprehensive Overview of New Transcatheter TR Therapies

Presenter: Rishi Puri

March 22, 2023

Advertisement

NT-proBNP Provides Info on Who Will Fare Well After Tricuspid TEER

Preclinical Results of a Novel, Percutaneous Device to Reapproximate and Reshape the Right Ventricle in Functional Tricuspid Regurgitation with Right Ventricular Dysfunction

Impact of Baseline Tricuspid Regurgitation on Outcomes in Heart Failure Patients Undergoing Mitral TEER

Central Venous Congestion in Transcatheter Tricuspid Repair: Lessons from the TRI.Fr Trial

Prognostic Value of NT-proBNP in Patients Undergoing Tricuspid Valve Transcatheter Edge-to-Edge Repair: The EuroTR Registry

Questioning the KCCQ: Experts Debate Its Validity as QoL Metric

Navigating Conduction Abnormalities Following Transcatheter Tricuspid Valve Replacement (TTVR): A Single Center Experience

Cardiomechanics in Patients Undergoing mTEER: Insights From PV Analysis

Strategies to Reduce the Burden of Residual MACE After mTEER in Patients With FMR

Pills, Drips and Pumps: Management of Volume Status and RV Dysfunction Before and After TTVI

Putting It All Together: A Case of TTVR

TTVI Trial Updates

TRISCEND II Trial: Right Heart Failure Outcomes in Patients With Severe Tricuspid Regurgitation at One Year

Case 5: Tricuspid TEER for the Win

Debating the Role of T-TEER in the Sickest Patients

HF Specialist Perspectives and Role in TR Management

Updates from Triluminate and TRISCEND II: Perspectives from the FDA Panel

Current Clinical Evidence Following TR Interventions

Treatment Algorithms: Matching Devices With Anatomy and Clinical Factors

A Comprehensive Overview of New Transcatheter TR Therapies

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content